14.59
Optimizerx Corp stock is traded at $14.59, with a volume of 258.22K.
It is up +7.44% in the last 24 hours and down -26.46% over the past month.
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
See More
Previous Close:
$13.58
Open:
$13.58
24h Volume:
258.22K
Relative Volume:
0.78
Market Cap:
$271.97M
Revenue:
$62.81M
Net Income/Loss:
$-13.75M
P/E Ratio:
-18.24
EPS:
-0.8
Net Cash Flow:
$153.00K
1W Performance:
-3.89%
1M Performance:
-26.46%
6M Performance:
+25.67%
1Y Performance:
+224.94%
Optimizerx Corp Stock (OPRX) Company Profile
Name
Optimizerx Corp
Sector
Industry
Phone
248-651-6558
Address
260 CHARLES STREET, WALTHAM, MI
Compare OPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
OPRX
Optimizerx Corp
|
14.59 | 253.14M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
244.06 | 44.34B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
70.29 | 11.69B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
101.91 | 8.68B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
50.42 | 8.74B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
35.74 | 6.66B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Feb-02-23 | Resumed | B. Riley Securities | Buy |
| Nov-01-22 | Initiated | Stifel | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| Oct-18-21 | Resumed | B. Riley Securities | Buy |
| Apr-13-21 | Initiated | RBC Capital Mkts | Outperform |
| Jan-03-19 | Initiated | William Blair | Outperform |
View All
Optimizerx Corp Stock (OPRX) Latest News
Connor Clark & Lunn Investment Management Ltd. Makes New Investment in OptimizeRx Corp. $OPRX - Defense World
Is OptimizeRx Corporation stock attractive for growth ETFs2025 Bull vs Bear & Daily Growth Stock Investment Tips - newser.com
P.A.W. Capital Corp Invests $675,000 in OptimizeRx Corp. $OPRX - MarketBeat
Can OptimizeRx Corporation stock deliver surprise earnings beat2025 Bull vs Bear & Verified Entry Point Detection - newser.com
Is a relief rally coming for OptimizeRx Corporation holdersInsider Selling & Fast Gain Swing Alerts - newser.com
Can OptimizeRx Corporation stock sustain market leadershipJuly 2025 Update & Technical Pattern Alert System - newser.com
Automated trading signals detected on OptimizeRx CorporationJuly 2025 WrapUp & Reliable Entry Point Trade Alerts - newser.com
Stephens Issues Pessimistic Forecast for OptimizeRx (NASDAQ:OPRX) Stock Price - MarketBeat
OptimizeRx : Corporate PresentationNovember 2025 - MarketScreener
How OptimizeRx Corporation stock performs in rate cut cyclesJuly 2025 Pullbacks & AI Optimized Trading Strategy Guides - newser.com
OptimizeRx (OPRX) Price Target Increased by 24.79% to 24.82 - Nasdaq
OptimizeRx (OPRX) Analyst Rating Update: Stephens & Co. Lowers P - GuruFocus
Los Angeles Capital Management LLC Makes New $349,000 Investment in OptimizeRx Corp. $OPRX - MarketBeat
When is the best time to exit OptimizeRx Corporation2025 Market Sentiment & Safe Entry Zone Tips - newser.com
Published on: 2025-11-16 12:30:34 - newser.com
Will OptimizeRx Corporation stock maintain momentum in 20252025 Valuation Update & AI Powered Market Trend Analysis - newser.com
Can a trend reversal in OptimizeRx Corporation lead to recoveryJuly 2025 Outlook & Reliable Intraday Trade Plans - newser.com
OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript - Yahoo Finance
OptimizeRx (NASDAQ:OPRX) Issues Earnings Results, Beats Expectations By $0.17 EPS - MarketBeat
OptimizeRx (NASDAQ:OPRX) Raised to Strong-Buy at Wall Street Zen - MarketBeat
ETFs Investing in OptimizeRx Corporation Stocks - TradingView
OptimizeRx Corporation (NASDAQ:OPRX) Q3 2025 Earnings Call Transcript - Insider Monkey
Citizens Maintains OptimizeRx (OPRX) Market Outperform Recommendation - MSN
OptimizeRx (NASDAQ:OPRX) Stock Price Expected to Rise, Citizens Jmp Analyst Says - MarketBeat
How Recent Upgrades Are Changing the OptimizeRx Story According to Analysts - Yahoo Finance
OptimizeRx Corp. (OPRX) Tops Q3 Earnings and Revenue Estimates - sharewise.com
[Form 4] OptimizeRx Corp Insider Trading Activity - Stock Titan
[10-Q] OptimizeRx Corp Quarterly Earnings Report | OPRX SEC FilingForm 10-Q - Stock Titan
OptimizeRx (OPRX) Analyst Rating Update: Price Target Raised to $24.00 | OPRX Stock News - GuruFocus
OptimizeRx Delivers Big Earnings Beat And Raises Outlook Again - Finimize
OptimizeRx Corp (OPRX) Q3 2025 Earnings Call Highlights: Transitioning to Predictive Revenue ... By GuruFocus - Investing.com Canada
OptimizeRx Corp (OPRX) Q3 2025 Earnings Call Highlights: Transitioning to Predictive Revenue ... - Yahoo Finance
Vanguard Group Inc's Strategic Acquisition of OptimizeRx Corp Sh - GuruFocus
Earnings call transcript: OptimizeRx’s Q3 2025 Earnings Beat Expectations - Investing.com
OPTIMIZERx earnings beat by $0.16, revenue topped estimates - Investing.com
OptimizeRx Corp reports results for the quarter ended September 30Earnings Summary - TradingView
OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance - The Manila Times
[8-K] OptimizeRx Corp Reports Material Event | OPRX SEC FilingForm 8-K - Stock Titan
OptimizeRx (Nasdaq: OPRX) raises full-year outlook to $105M-$109M; updates EBITDA view - Stock Titan
Will OptimizeRx Corporation stock deliver better than expected guidanceWeekly Trend Recap & High Return Trade Opportunity Guides - newser.com
Optimizerx Corp Stock (OPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Optimizerx Corp Stock (OPRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
6,649 |
0 |
190,536 |
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Sale |
18.75 |
1,620 |
30,375 |
188,916 |
| Stelmakh Edward | Chief Finance & Strat Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
16,623 |
0 |
127,387 |
| Besch Doug | Chief Product & Tech Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
3,325 |
0 |
70,555 |
| Spangler Patrick D | Director |
Aug 28 '25 |
Sale |
17.49 |
11,120 |
194,489 |
44,215 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):